What is really going on here
Terrible time of teh year to be crunched - lawyers , bankers and brokers on holidays Dec- Feb
August conference call says they were going to partner out neurmodulation
What happened - did all discussions fail?
Did they open up the data room?
Who saw the 1st in man results and data?
Is Erb got them to the trough but can't make em drink so he is putting the squeeze back on possible partner to hurry up? Does partner want control and it unlisted?
Is it just existing holders getting squeezed?
Need to know what sucess in 1st man trial really means
Trump reckons he will change pathways through FDA- how long will that take
SSH said they can do neuromodulation at half price and half time of C-pulse. Just what time was it to get c-pulse fully approved estimated to be and at what cost?
SHC Price at posting:
2.5¢ Sentiment: None Disclosure: Not Held